photo of

Details

Role Group Leader / Honorary Fellow Manager
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.

Top Publications

  • Garland, SM. The Australian Experience With the Human Papillomavirus Vaccine. Clinical Therapeutics 36(1) : 17 -23 2014
    view publication
  • Jacobs, SE, Tobin, JM, Opie, GF, Donath, S, Tabrizi, SN, Pirotta, M, Morley, CJ, Garland, SM. Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled Trial. Pediatrics 132(6) : 1055 -1062 2013
    view publication
  • Young, EJ, Tabrizi, SN, Brotherton, JM, Wark, JD, Pyman, J, Saville, M, Wrede, CD, Jayasinghe, Y, Tan, J, Gertig, DM, et al. Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study). BMC Cancer 13(1) : 296 2013
    view publication
  • Machalek, DA, Grulich, AE, Hillman, RJ, Jin, F, Templeton, DJ, Tabrizi, SN, Garland, SM, Prestage, G, McCaffery, K, Howard, K, et al. The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC Public Health 13(1) : 946 2013
    view publication
  • Tobin, JM, Garland, SM, Jacobs, SE, Pirotta, M, Tabrizi, SN. Rapid assay to assess colonization patterns following in-vivo probiotic ingestion. BMC Research Notes 6(1) : 252 2013
    view publication